Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$62.69 - $88.44 $67,266 - $94,896
-1,073 Closed
0 $0
Q1 2022

Apr 12, 2022

SELL
$63.15 - $90.42 $108,554 - $155,431
-1,719 Reduced 61.57%
1,073 $84,000
Q4 2021

Jan 18, 2022

BUY
$77.28 - $99.42 $215,765 - $277,580
2,792 New
2,792 $251,000
Q3 2021

Oct 18, 2021

SELL
$65.97 - $92.48 $105,947 - $148,522
-1,606 Closed
0 $0
Q2 2021

Jul 16, 2021

SELL
$69.38 - $86.75 $222,779 - $278,554
-3,211 Reduced 66.66%
1,606 $125,000
Q1 2021

Apr 09, 2021

BUY
$72.25 - $168.95 $338,780 - $792,206
4,689 Added 3663.28%
4,817 $359,000
Q4 2020

Jan 11, 2021

BUY
$125.56 - $178.74 $15,192 - $21,627
121 Added 1728.57%
128 $22,000
Q3 2020

Oct 23, 2020

BUY
$127.12 - $172.34 $889 - $1,206
7 New
7 $1,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.